ALB and metabolic dysfunction-associated steatotic liver disease: In consideration of previous reports that patients with greater declines in serum albumin during follow-up have a poorer prognosis [26], BCAA administration to the intermediate albumin group may be beneficial to improve the prognosis of patients with NAFLD.